Immune checkpoint inhibitor related nephrotoxicity: Advances in clinicopathologic features, noninvasive approaches, and therapeutic strategy and rechallenge is a research paper published in Frontiers in Nephrology (2022). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 DK130839
National Institutes of Health
Grant: 1R01DK130839-01
Mechanisms driving acute and chronic kidney function decline after immune checkpoint inhibitor therapy for cancer
National Institutes of Health
Grant: 5K08DK118120-04
Hypoxic preconditioning for the improvement of the regenerative capacity of adipose-derived mesenchymal stem cells and its application in chronic kidney disease due to hypertensive nephropathy
National Institutes of Health
Grant: 3UL1TR002377-04S5
Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Regan Theiler)
National Institutes of Health
FWCI
1.58
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals